Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Dilaudid SR and IR in Chronic Pain
NCT00410943Phase 3Completed
- Sponsor
- ALZA Corporation
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of hydromorphone in chronic pain, sponsored by ALZA Corporation. Status: completed.
02
Drugs
hydromorphone
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT00410943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00410943.